Assenagon Asset Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,896
| Closed | -$269K | – | 1458 |
|
|
2024
Q1 | $269K | Buy |
28,896
+10,936
| +61% | +$102K | ﹤0.01% | 1269 |
|
|
2023
Q4 | $152K | Sell |
17,960
-16,199
| -47% | -$137K | ﹤0.01% | 1329 |
|
|
2023
Q3 | $265K | Sell |
34,159
-165,333
| -83% | -$1.28M | ﹤0.01% | 1264 |
|
|
2023
Q2 | $2.28M | Buy |
199,492
+86,327
| +76% | +$988K | 0.01% | 706 |
|
|
2023
Q1 | $873K | Buy |
+113,165
| New | +$873K | ﹤0.01% | 1058 |
|
|
2022
Q4 | – | Sell |
-16,224
| Closed | -$96K | – | 1408 |
|
|
2022
Q3 | $96K | Sell |
16,224
-3,517
| -18% | -$20.8K | ﹤0.01% | 1250 |
|
|
2022
Q2 | $117K | Buy |
+19,741
| New | +$117K | ﹤0.01% | 1356 |
|
|
2021
Q4 | – | Sell |
-52,547
| Closed | -$138K | – | 1522 |
|
|
2021
Q3 | $138K | Sell |
52,547
-41,580
| -44% | -$109K | ﹤0.01% | 1210 |
|
|
2021
Q2 | $389K | Sell |
94,127
-185,946
| -66% | -$768K | ﹤0.01% | 1032 |
|
|
2021
Q1 | $1.32M | Buy |
280,073
+63,914
| +30% | +$301K | 0.01% | 801 |
|
|
2020
Q4 | $1.55M | Buy |
216,159
+75,757
| +54% | +$542K | 0.01% | 552 |
|
|
2020
Q3 | $1.5M | Buy |
+140,402
| New | +$1.5M | 0.01% | 626 |
|